Home
BML Investment Partners reported a 10.7% stake in AN2 Therapeutics ANTX · 3,217,423 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 10.7%
- Last report
- 19.1% · filed 25/05/07
- Shares held
- 3,217,423 sh
- Class
- Common Stock, par value $0.00001 per share
- Holder
- BML Investment Partners
- Event date
- 25/05/28
- Filed
- 25/05/30
10.7% stake · −8.4pp from the last report
- Stake
- 10.7%
- Last report
- 19.1%
- Since last report
- −8.4pp
AN2 Therapeutics trades, last 26 weeks
What else happened in AN2 Therapeutics around then
Filed or reported within 30 days of the trade day · 25/04/28~25/06/27BML Investment Partners's other 5% stake reports
- BML Investment Partners
5% stakeOramed Pharmaceuticals
5% stakeOramed Pharmaceuticals
ORMP
2.5% stake
1,026,269 sh
2.5% stake
Filed 06/29
- BML Investment Partners
5% stakeOutset Medical
5% stakeOutset Medical
OM
13.6% stake
2,519,701 sh
13.6% stake
Filed 05/18
- BML Investment Partners
5% stakeenGene Therapeutics
5% stakeenGene Therapeutics
ENGN
9.95% stake
6,669,908 sh
9.95% stake
Filed 05/14
- BML Investment Partners
5% stakeenGene Therapeutics
5% stakeenGene Therapeutics
ENGN
7.8% stake
5,225,000 sh
7.8% stake
Filed 05/13
- BML Investment Partners
5% stakeOutset Medical
5% stakeOutset Medical
OM
11.8% stake
2,196,701 sh
11.8% stake
Filed 05/12
